SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-05-021636
Filing Date
2005-04-21
Accepted
2005-04-21 15:57:54
Documents
1
Period of Report
2005-04-11

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bsf08043_da3.html 3  
1 MAIN DOCUMENT DESCRIPTION bsf08043_da3.xml 3 5143
  Complete submission text file 0001209191-05-021636.txt   7073
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELL GENESYS INC 500 FORBES BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 650 266 3000
ANDO DALE G (Reporting) CIK: 0001202278 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-30171 | Film No.: 05764826